Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VIVO Cannabis Inc. VVCIF

Healthcare Drug Manufacturers - Specialty & Generic
VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

VIVO Cannabis Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by dubiousoneon May 29, 2019 9:36pm
141 Views
Post# 29783634

RE:Took a position at .70!!!

RE:Took a position at .70!!!Loss wasnt too too too bad. $68M cash still and expanding with CO2 extraction and they’re moving ahead with Germany and Australia as planned. So they have the funds to move forward without going to the market for funding. 

Theyve been operating at 5k capacity so the added capacity’s going to help them eclipse their losses. 

and possibly hit on something with their medical divisions or edibles that’s not being priced into current share price. 

reefercat wrote: And I'm pretty happy with it. Financials were good. Net income instead of loss. Even if you knock off the unexpected 8.9m. The net loss would have been 3.9m so less then half the 8m from quarter 4 of 2018. Slightly over 10,000 kilograms production in 2019 at 7.70 a gram. 77 million dollars sounds good to me.


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities